AU5050899A - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
AU5050899A
AU5050899A AU50508/99A AU5050899A AU5050899A AU 5050899 A AU5050899 A AU 5050899A AU 50508/99 A AU50508/99 A AU 50508/99A AU 5050899 A AU5050899 A AU 5050899A AU 5050899 A AU5050899 A AU 5050899A
Authority
AU
Australia
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50508/99A
Inventor
Alan John Nelson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ligand UK Research Ltd
Original Assignee
Cerebrus Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerebrus Pharmaceuticals Ltd filed Critical Cerebrus Pharmaceuticals Ltd
Publication of AU5050899A publication Critical patent/AU5050899A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU50508/99A 1998-07-20 1999-07-19 Chemical compounds Abandoned AU5050899A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9815785 1998-07-20
GBGB9815785.2A GB9815785D0 (en) 1998-07-20 1998-07-20 Chemical compounds
PCT/GB1999/002311 WO2000004888A2 (en) 1998-07-20 1999-07-19 Use of cyclodextrins for the treatment of cerebral ischaemia and central nervous system injury

Publications (1)

Publication Number Publication Date
AU5050899A true AU5050899A (en) 2000-02-14

Family

ID=10835840

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50508/99A Abandoned AU5050899A (en) 1998-07-20 1999-07-19 Chemical compounds

Country Status (3)

Country Link
AU (1) AU5050899A (en)
GB (1) GB9815785D0 (en)
WO (1) WO2000004888A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982256B2 (en) 2001-09-07 2006-01-03 Boehringer Ingelheim Pharma Kg Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-benzoylguanidine in intravenous administration
LU100797B1 (en) * 2018-05-15 2019-11-15 Univ Luxembourg 2-hydroxypropyl-beta-cyclodextrin for use in a method of treatment of a parkinsonian condition
EP4458362A1 (en) * 2021-12-31 2024-11-06 Hangzhou Adamerck Pharmlabs Inc. Cardiovascular and cerebrovascular drug and use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6130519A (en) * 1984-07-23 1986-02-12 Dainippon Pharmaceut Co Ltd Remedy for anoxic disease of cerebral nervous cell
US5760015A (en) * 1988-01-19 1998-06-02 The Trustees Of The University Of Pennsylvania Cyclodextrin compounds and methods of making and use thereof
US5180716A (en) * 1990-08-01 1993-01-19 The Regents Of The University Of California Cyclodextrin complexes for neuraxial administration of drugs
ZW1992A1 (en) * 1991-02-25 1993-09-22 Janssen Pharmaceutica Nv 4-/(2-benzotiazolyl)methylamino/-b-/(3,4-difluorephenoxy)methyl/-1-piperidine ethanol
US5298410A (en) * 1993-02-25 1994-03-29 Sterling Winthrop Inc. Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life
HU223475B1 (en) * 1994-10-24 2004-07-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Liposome composition containing selegiline and process for it`s preparation
US5840713A (en) * 1995-04-03 1998-11-24 Weisz; Paul B. Therapy for tissue membrane insufficiency
US5834446A (en) * 1996-06-21 1998-11-10 Queen's University At Kingston Nerve process growth modulators

Also Published As

Publication number Publication date
GB9815785D0 (en) 1998-09-16
WO2000004888A3 (en) 2000-04-27
WO2000004888A2 (en) 2000-02-03

Similar Documents

Publication Publication Date Title
AU2093597A (en) Chemical compounds
GB9800428D0 (en) Chemical compounds
GB9812709D0 (en) Chemical compounds
GB9811159D0 (en) Chemical compounds
AU5052199A (en) Chemical compounds
AU1424200A (en) Compounds
GB9812088D0 (en) Chemical compounds
AU4501699A (en) Aminoazole compounds
AU5637499A (en) Chemical compounds iii
GB9804343D0 (en) Chemical compounds
AU6104599A (en) Chemical compounds viii
AU1434500A (en) Compounds
GB9804861D0 (en) Chemical compounds
AU1872900A (en) Chemical compounds
AU5050899A (en) Chemical compounds
GB9801812D0 (en) Chemical compounds
AU5661399A (en) Compounds
GB9802028D0 (en) Chemical compounds
AU5689400A (en) Chemical compounds
AU3715899A (en) Di-peroxy compounds
GB9809161D0 (en) Chemical compounds
AUPP298598A0 (en) Neurologically-active compounds
AUPP499898A0 (en) Chemical methods
GB9807576D0 (en) Chemical compounds
GB9801674D0 (en) Chemical compounds

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase